Regulatory Affairs In The Pharmaceutical Industry
Download Regulatory Affairs In The Pharmaceutical Industry full books in PDF, epub, and Kindle. Read online free Regulatory Affairs In The Pharmaceutical Industry ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: Javed Ali |
Publisher |
: Academic Press |
Total Pages |
: 287 |
Release |
: 2021-11-14 |
ISBN-10 |
: 9780128222232 |
ISBN-13 |
: 0128222239 |
Rating |
: 4/5 (32 Downloads) |
Synopsis Regulatory Affairs in the Pharmaceutical Industry by : Javed Ali
Regulatory Affairs in the Pharmaceutical Industry is a comprehensive reference that compiles all the information available pertaining to regulatory procedures currently followed by the pharmaceutical industry. Designed to impart advanced knowledge and skills required to learn the various concepts of regulatory affairs, the content covers new drugs, generic drugs and their development, regulatory filings in different countries, different phases of clinical trials, and the submission of regulatory documents like IND (Investigational New Drug), NDA (New Drug Application) and ANDA (Abbreviated New Drug Application). Chapters cover documentation in the pharmaceutical industry, generic drug development, code of Federal Regulation (CFR), the ANDA regulatory approval process, the process and documentation for US registration of foreign drugs, the regulation of combination products and medical devices, the CTD and ECTD formats, and much more. Updated reference on drug approval processes in key global markets Provides comprehensive coverage of concepts and regulatory affairs Presents a concise compilation of the regulatory requirements of different countries Introduces the fundamentals of manufacturing controls and their regulatory importance
Author |
: Javed Ali |
Publisher |
: Elsevier |
Total Pages |
: 286 |
Release |
: 2021-11-15 |
ISBN-10 |
: 9780128222119 |
ISBN-13 |
: 0128222115 |
Rating |
: 4/5 (19 Downloads) |
Synopsis Regulatory Affairs in the Pharmaceutical Industry by : Javed Ali
Regulatory Affairs in the Pharmaceutical Industry is a comprehensive reference that compiles all the information available pertaining to regulatory procedures currently followed by the pharmaceutical industry. Designed to impart advanced knowledge and skills required to learn the various concepts of regulatory affairs, the content covers new drugs, generic drugs and their development, regulatory filings in different countries, different phases of clinical trials, and the submission of regulatory documents like IND (Investigational New Drug), NDA (New Drug Application) and ANDA (Abbreviated New Drug Application). Chapters cover documentation in the pharmaceutical industry, generic drug development, code of Federal Regulation (CFR), the ANDA regulatory approval process, the process and documentation for US registration of foreign drugs, the regulation of combination products and medical devices, the CTD and ECTD formats, and much more. Updated reference on drug approval processes in key global markets Provides comprehensive coverage of concepts and regulatory affairs Presents a concise compilation of the regulatory requirements of different countries Introduces the fundamentals of manufacturing controls and their regulatory importance
Author |
: Ilamathi.A.S |
Publisher |
: Writers Corner Publication |
Total Pages |
: 13 |
Release |
: 2024-04-03 |
ISBN-10 |
: 9798321819531 |
ISBN-13 |
: |
Rating |
: 4/5 (31 Downloads) |
Synopsis REVIEW ON PHARMACEUTICAL REGULATORY AFFAIRS by : Ilamathi.A.S
ABSTRACT: Regulatory affairs in the pharmaceutical industry play an important role in ensuring the safety, efficacy, and quality of medicinal products worldwide. The pharmaceutical drug regulatory affairs profession was developed from the desire all over the world to protect public health by providing good quality medicine including safety and efficacy in the area of not only pharmacy but also in the area of veterinary medicine, medical devices, insecticides, pesticides, agrochemical, cosmetic and complementary medicine. Regulatory affairs acts as an interface between the pharmaceutical company and the regulatory agencies. The key role of regulatory affairs professions includes maintaining Compliance, Product approval, Risk management, Market access, Quality assurance. It works under proper organizational structure and various regulatory bodies around the world. Regulatory affairs professional also involves in clinical trail and R&D to develop innovative products that take advantage of new technological and regulatory developments to accelerate time to market. They can face regulatory non-compliance issues, but drug developers can also look to tech-enabled solutions to improve regulatory compliance. Regulatory affairs should explore whether the different innovation in pharma can decrease the risk of compliance issues.
Author |
: Thomas Jacobsen |
Publisher |
: Jones & Bartlett Learning |
Total Pages |
: 346 |
Release |
: 2010-10-25 |
ISBN-10 |
: 9780763766368 |
ISBN-13 |
: 0763766364 |
Rating |
: 4/5 (68 Downloads) |
Synopsis Modern Pharmaceutical Industry by : Thomas Jacobsen
With its expansion into the global marketplace, the pharmaceutical industry of today is uniquely positioned to improve the global health standards of society by saving lives and improving the quality of lives around the world. Modern Pharmaceutical Industry: A Primer comprehensively explains the broad range of divisions in this complex industry. Experts actively involved in each division discuss their own contribution to a pharmaceutical company's work and success. Divisions include regulatory affairs, research and development, intellectual property, pricing, marketing, generics, OTC, and more
Author |
: John J. Tobin |
Publisher |
: John Wiley & Sons |
Total Pages |
: 304 |
Release |
: 2011-08-24 |
ISBN-10 |
: 9783527644711 |
ISBN-13 |
: 3527644717 |
Rating |
: 4/5 (11 Downloads) |
Synopsis Medical Product Regulatory Affairs by : John J. Tobin
Written in a clear and concise style by an experienced author, this attractively-priced book covers regulatory affairs in all major global markets for pharmaceuticals and medical devices, making it the most comprehensive in its field. Following a look at drug development, complete sections are devoted to national and EU regulatory issues, manufacturing license application and retention, and regulation in the USA. Other topics dealt with include CDER, CBER and marketing and manufacturing licenses, the ICH process and Good Laboratory/Clinical/Manufacturing Practices. Everything pharmacologists, bioengineers, pharma engineers, students in pharmacy and those working in the pharmaceutical industry need to know about medical regulatory affairs.
Author |
: Patrick M. Malone |
Publisher |
: McGraw Hill Professional |
Total Pages |
: 907 |
Release |
: 2010-05-12 |
ISBN-10 |
: 9780071492034 |
ISBN-13 |
: 0071492038 |
Rating |
: 4/5 (34 Downloads) |
Synopsis Drug Information by : Patrick M. Malone
Extensive coverage of the Internet as a source of and distribution means for drug information, and detailed sections on evaluating medical literature from clinical trials Audience includes Pharmacists, Pharmacy students and Pharmacy schools Updated to include using PDAs for medication information Covers the ethical and legal aspects of drug information management Nothing else like it on the market
Author |
: Dr. Jayesh Dhalani |
Publisher |
: Lulu.com |
Total Pages |
: 127 |
Release |
: |
ISBN-10 |
: 9780359963232 |
ISBN-13 |
: 0359963234 |
Rating |
: 4/5 (32 Downloads) |
Synopsis Basics of Regulatory Affairs for Pharma Professional by : Dr. Jayesh Dhalani
Author |
: C. F. Harrison |
Publisher |
: Createspace Independent Publishing Platform |
Total Pages |
: 66 |
Release |
: 2016-08-19 |
ISBN-10 |
: 1537090747 |
ISBN-13 |
: 9781537090740 |
Rating |
: 4/5 (47 Downloads) |
Synopsis Pharmaceutical Regulatory Affairs by : C. F. Harrison
Regulatory affairs. If you're finishing your academic career and are looking for a job in biotech or pharmaceuticals, you will have seen a thousand advertisements for regulatory affairs managers. But...what exactly is regulatory affairs? What would I be doing? What sort of skills do I need? What do I need to know before I start? This book answers all these questions and more, providing an introduction to the complex world of regulatory affairs. We cover typical tasks; required skills; the ins and outs of the submission process; vital knowledge you'll need to have; and much more. Lost in a sea of acronyms? We've got you covered. Not really sure how regulatory fits into pharmaceutical development? We explain the process. No idea why your new boss keeps going on about module 3.2.P.7? No problem. Whether you're looking for a job, preparing for an interview, or have just started in the field, this book will give you the foundational knowledge you need to succeed.
Author |
: Dr. S. Valarmathi, Dr. Anasuya Patil, Dr. Abhishek Suman, Mr Vinay Kumar Yanmandru, Dr. NARLA SUNITHA, Prof. (Dr.) Varsha Deva |
Publisher |
: Shashwat Publication |
Total Pages |
: 452 |
Release |
: 2023-08-04 |
ISBN-10 |
: 9788119281244 |
ISBN-13 |
: 8119281241 |
Rating |
: 4/5 (44 Downloads) |
Synopsis TEXTBOOK ON PHARMACEUTICAL REGULATORY AFFAIRS by : Dr. S. Valarmathi, Dr. Anasuya Patil, Dr. Abhishek Suman, Mr Vinay Kumar Yanmandru, Dr. NARLA SUNITHA, Prof. (Dr.) Varsha Deva
This book structured in TWO different parts. These parts are as follows: Part I emphasizes on GCP (Good Clinical Practices), GLP (Good Laboratory Practices), GMP (Good Manufacturing Practices), USFDA-NDA/ANDA (U S Food and Drug Administrations- New Drug Approval/Abbreviated New Drug Approval) and TQM (Total Quality Management). GCP (Good Clinical Practices) is an international quality standard that is provided by International Conference on Harmonization (ICH), an international body that defines standards, which governments can transpose into regulations for clinical trials involving human subjects. Good Clinical Practice guidelines include protection of human rights as a subject in clinical trial. It also provides assurance of the safety and efficacy of the newly developed compounds. Good Clinical Practice Guidelines include standards on how clinical trials should be conducted, define the roles and responsibilities of clinical trial sponsors, clinical research investigators, and monitors. In the pharmaceutical industry monitors are often called Clinical Research Associates. GLP (Good Laboratory Practices) deals with the organization, process and conditions under which laboratory studies are planned, performed, monitored, recorded and reported. GLP practices are intended to promote the quality and validity of test data. Published GLP regulations and guidelines have a significant impact on the daily operation of an analytical laboratory. GMP (Good Manufacturing Practices) Manufacturing relies on the ability to reproduce exactly a single product hundreds, if not thousands, of times. To make this possible, guidelines have been drawn up in most countries that are similar to the FDA ones described here that define GMPs. Diagnostic companies, including those manufacturing and distributing biosensors, cannot sell their products for either public or professional use unless they have been approved on the basis of these guidelines. USFDA-NDA/ANDA (U S Food and Drug Ad
Author |
: Raymond A. Huml |
Publisher |
: Springer Science & Business Media |
Total Pages |
: 94 |
Release |
: 2012-06-15 |
ISBN-10 |
: 9781461436829 |
ISBN-13 |
: 1461436826 |
Rating |
: 4/5 (29 Downloads) |
Synopsis Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional by : Raymond A. Huml
This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry. It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These apply particularly to evaluations that focus on outputs such as regulatory approval, or the commercial impact of product labeling on the sales forecast over a limited timeframe. The Brief also provides an overview of intellectual property assessment that can impact a product’s lifespan on the market due to patent protection itself (or loss of patent protection) or via regulatory exclusivity. Case examples are discussed to illustrate the importance of keeping up with the ever-changing regulations, and how to interpret them in the context of CI. In addition, there is a section on virtual data rooms (VDRs) which currently function as the cornerstone of due diligence investigations. While aimed primarily at regulatory affairs professionals in the United States, this publication provides a useful adjunct for other pharmaceutical executives, especially those new to product-based investments, and regulatory affairs professionals in other regions.